Apellis Pharmaceuticals shares owned by Rhenman & Partners Asset Management AB
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Rhenman & Partners Asset Management AB
from 13F filings
Historical chart of Rhenman & Partners Asset Management AB investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Apellis Pharmaceuticals by Rhenman & Partners Asset Management AB
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $11M | 368k | 28.84 |
2024-06-30 | $2.1M | 55k | 38.36 |
2024-03-31 | $11M | 178k | 58.78 |
2023-09-30 | $17M | 190k | 91.10 |
2023-06-30 | $17M | 190k | 91.10 |
2023-03-31 | $12M | 185k | 66.02 |
2022-12-31 | $10M | 200k | 51.71 |
2022-09-30 | $13M | 220k | 60.49 |
2022-06-30 | $9.5M | 210k | 45.22 |
2022-03-31 | $19M | 377k | 50.81 |
2021-12-31 | $21M | 430k | 47.95 |
2021-09-30 | $19M | 561k | 32.96 |
2021-06-30 | $19M | 305k | 63.20 |
2021-03-31 | $12M | 270k | 42.91 |
2020-12-31 | $15M | 270k | 57.20 |
2020-09-30 | $6.8M | 225k | 30.17 |
2020-06-30 | $5.4M | 165k | 32.66 |
2020-03-31 | $2.7M | 100k | 26.79 |
2019-12-31 | $2.4M | 80k | 30.62 |
More positions owned by Rhenman & Partners Asset Management AB
View all positions for Rhenman & Partners Asset Management AB